OTLK, WDC, AMAT Surge Up to 44.5% on EPS Revisions and Catalysts
Stocks detected by our EPS revision screener delivered strong gains, led by Outlook Therapeutics (+44.5%) after its BLA resubmission was accepted by the FDA. Western Digital (+34.2%), Applied Materials (+24.5%), Ultra Clean Holdings (+24.1%), and Seagate Technology (+23.3%) also rallied as analysts raised forward earnings growth estimates amid AI-driven demand and macro shifts.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| OTLK | Healthcare | 2026-06-11 | +4.8pp | +44.5% |
| WDC | Technology | 2026-06-11 | N/A | +34.2% |
| AMAT | Technology | 2026-06-10 | N/A | +24.5% |
| UCTT | Technology | 2026-06-09 | +3.5pp | +24.1% |
| STX | Technology | 2026-06-11 | N/A | +23.3% |
Why did OTLK stock jump in June 2026?
OTLK jumped 44.5% (from $1.10 to $1.59) after analysts raised its forward EPS growth estimate from 48.3% to 53.0% on June 11.
The FDA accepted the resubmitted BLA for wet AMD treatment ONS-5010/LYTENAVA on June 16, setting a PDUFA date of July 29, 2026. The news reinforced the positive revision, signaling potential approval of the first FDA-approved ophthalmic bevacizumab formulation. The screener caught the estimate upgrade early, and the price gain accelerated after the regulatory milestone.
OTLK EPS revision history → · Screener snapshot from 2026-06-11 →
FAQ: OTLK
Why did OTLK stock jump in June 2026?
OTLK surged 44.5% from $1.10 to $1.59 after analysts lifted its forward EPS growth estimate from 48.3% to 53.0% on June 11, and the FDA accepted its BLA resubmission for wet AMD on June 16.
What is OTLK's EPS growth estimate?
OTLK's forward EPS growth estimate was revised upward from 48.3% to 53.0% as of June 11, 2026.
What caused OTLK's surge?
The rally was driven by an upward EPS revision and the FDA's acceptance of the resubmitted BLA for ONS-5010/LYTENAVA, with a PDUFA target date of July 29, 2026.
Why did WDC stock jump in June 2026?
WDC jumped 34.2% (from $529.29 to $710.57) after analysts raised its forward EPS growth estimate to 76.4% as of June 11.
A June 15 preliminary Iran peace deal lifted travel and cyclical stocks, with WDC outperforming airlines as investors rotated into economically sensitive names. The EPS revision reflected optimism around memory demand, and the macro catalyst accelerated the price gain. The screener identified the estimate upgrade before the rotation broadened.
WDC EPS revision history → · Screener snapshot from 2026-06-11 →
FAQ: WDC
Why did WDC stock jump in June 2026?
WDC rose 34.2% from $529.29 to $710.57 after its forward EPS growth estimate was raised to 76.4% and a preliminary Iran peace deal spurred a rotation into cyclical stocks.
Is WDC a buy after the rally?
The rally reflects a higher EPS growth estimate (76.4%) and a favorable macro catalyst, but investors should monitor memory market trends and geopolitical developments.
What is WDC's EPS growth estimate?
As of June 11, 2026, WDC's forward EPS growth estimate stood at 76.4%.
Why did AMAT stock jump in June 2026?
AMAT jumped 24.5% (from $497.01 to $618.84) after analysts raised its forward EPS growth estimate to 34.3% as of June 10.
Citi raised its price target to $710 from $550 on June 17, citing booming wafer fab equipment demand from AI and memory expansion. Morningstar highlighted the AI-driven growth cycle for chip equipment, reinforcing the estimate revision. The screener detected the upgrade before the analyst upgrades and sector momentum pushed the stock higher.
AMAT EPS revision history → · Screener snapshot from 2026-06-10 →
FAQ: AMAT
Why did AMAT stock jump in June 2026?
AMAT surged 24.5% from $497.01 to $618.84 after its forward EPS growth estimate was raised to 34.3% and Citi lifted its price target to $710 on booming AI-driven WFE demand.
What is AMAT's EPS growth estimate?
AMAT's forward EPS growth estimate was 34.3% as of June 10, 2026.
What caused AMAT's surge?
The rise was powered by an upward EPS revision and analyst upgrades, including Citi's price target increase to $710, driven by AI infrastructure buildout and memory supply constraints.
Why did UCTT stock jump in June 2026?
UCTT jumped 24.1% (from $91.88 to $114.04) after analysts raised its forward EPS growth estimate from 83.2% to 86.8% on June 9.
No major news followed, but the semiconductor equipment sub-sector rallied on sustained AI demand and supply chain tightness. The estimate revision signaled stronger earnings momentum, and the stock gained as investors rotated into AI-adjacent manufacturing plays. The screener caught the upgrade early, before the broader tech rally.
UCTT EPS revision history → · Screener snapshot from 2026-06-09 →
FAQ: UCTT
Why did UCTT stock jump in June 2026?
UCTT rose 24.1% from $91.88 to $114.04 after its forward EPS growth estimate was raised from 83.2% to 86.8% on June 9, reflecting strong semiconductor equipment demand.
What is UCTT's EPS growth estimate?
UCTT's forward EPS growth estimate was revised from 83.2% to 86.8% as of June 9, 2026.
What caused UCTT's surge?
The surge was driven by the upward EPS revision and sector-wide momentum in semiconductor equipment, fueled by AI infrastructure expansion.
Why did STX stock jump in June 2026?
STX jumped 23.3% (from $868.09 to $1070.43) after analysts raised its forward EPS growth estimate to 82.0% as of June 11.
No company-specific news emerged, but the broader memory and storage sector rallied on expectations of surging HDD demand from AI data centers. The estimate revision captured improving fundamentals, and the stock followed peers like WDC higher. The screener identified the upgrade before the sector rotation materialized.
STX EPS revision history → · Screener snapshot from 2026-06-11 →
FAQ: STX
Why did STX stock jump in June 2026?
STX gained 23.3% from $868.09 to $1070.43 after its forward EPS growth estimate was raised to 82.0%, with sector tailwinds from AI-driven storage demand.
Is STX a buy after the rally?
The EPS revision to 82.0% growth suggests strong earnings potential, but investors should assess HDD pricing and AI capex sustainability.
What is STX's EPS growth estimate?
As of June 11, 2026, STX's forward EPS growth estimate was 82.0%.
Today's performers highlight how early detection of upward EPS revisions, combined with sector catalysts like FDA decisions or AI demand, can drive outsized gains. The market rewarded stocks where analyst optimism was confirmed by news or macro trends, reinforcing the value of revision-based screening.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →